Table 1 Demographic, clinical and biomarker data of the cohort
Whole sample | SCD | MCI | |
|---|---|---|---|
N | 18 | 13 (72.22%) | 5 (28.78%) |
Age (y) | 73.94 ± 6.27 | 72.62 ± 6.75 | 77.40 ± 3.13 |
Sex (female) | 9 (50.00%) | 6 (46.15%) | 3 (60.00%) |
Education (y) | 15.22 ± 4.68 | 15.46 ± 4.29 | 14.60 ± 6.11 |
MMSE score | 29.22 ± 1.06 | 29.62 ± 0.65 | 28.20 ± 1.30 |
APOE ε4 carriers | 11 (61.11%) | 9 (69.23%) | 2 (40.00%) |
FBB CL | 57.13 [17.14, 159.08] | 50.01 [17.14, 153.81] | 75.65 [30.17, 159.08] |
Time between FBB and PI-2620 PETs (m) | 10.79 ± 1.86 | 10.81 ± 2.06 | 10.76 ± 1.41 |
Time between PI-2620 and RO948 (m) | 0.89 ± 0.93 | 1.00 ± 1.00 | 0.58 ± 0.70 |